ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,275.38
0.54%
Dow Jones
38,686.32
1.51%
Gold vs US Dollar
2,327.355
0.00%
Brent Oil
81.295
0.00%
Bitcoin
67,783.86
0.09%
Pepperstone
Advertisement
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. USOTC
  6. Acura Pharmaceuticals Inc (CE) (ACUR)

  7. Acura Pharmaceuticals Inc (CE) (ACUR) News

Acura Pharmaceuticals (CE) (ACUR)

Acura Pharmaceuticals Inc (CE)
Date:
Sort by:
 Showing the most relevant articles for your search:USOTC:ACUR
DateTimeSourceHeadlineSymbolCompany
15/05/202413:00Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBUSOTC:ACURAcura Pharmaceuticals Inc (CE)
14/05/202421:40Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ACURAcura Pharmaceuticals Inc (CE)
14/02/202415:53Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ACURAcura Pharmaceuticals Inc (CE)
02/02/202415:27Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ACURAcura Pharmaceuticals Inc (CE)
10/01/202422:13Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ACURAcura Pharmaceuticals Inc (CE)
02/01/202420:23Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:ACURAcura Pharmaceuticals Inc (CE)
02/01/202420:23Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:ACURAcura Pharmaceuticals Inc (CE)
02/01/202420:20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:ACURAcura Pharmaceuticals Inc (CE)
02/01/202420:20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:ACURAcura Pharmaceuticals Inc (CE)
21/12/202317:01Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ACURAcura Pharmaceuticals Inc (CE)
06/12/202319:35Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ACURAcura Pharmaceuticals Inc (CE)
20/11/202317:08Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:ACURAcura Pharmaceuticals Inc (CE)
20/11/202317:08Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:ACURAcura Pharmaceuticals Inc (CE)
20/11/202317:07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:ACURAcura Pharmaceuticals Inc (CE)
20/11/202317:07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:ACURAcura Pharmaceuticals Inc (CE)
03/11/202316:42Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBUSOTC:ACURAcura Pharmaceuticals Inc (CE)
12/10/202317:05Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ACURAcura Pharmaceuticals Inc (CE)
25/09/202321:10Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ACURAcura Pharmaceuticals Inc (CE)
01/09/202312:00Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ACURAcura Pharmaceuticals Inc (CE)
31/08/202321:10Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ACURAcura Pharmaceuticals Inc (CE)
30/08/202321:10Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ACURAcura Pharmaceuticals Inc (CE)
16/08/202316:20Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ACURAcura Pharmaceuticals Inc (CE)
10/08/202317:17Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBUSOTC:ACURAcura Pharmaceuticals Inc (CE)
28/07/202321:41Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ACURAcura Pharmaceuticals Inc (CE)
28/07/202316:50Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ACURAcura Pharmaceuticals Inc (CE)
13/07/202314:00Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ACURAcura Pharmaceuticals Inc (CE)
30/06/202319:04Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ACURAcura Pharmaceuticals Inc (CE)
30/06/202318:00Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]USOTC:ACURAcura Pharmaceuticals Inc (CE)
30/06/202316:53Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ACURAcura Pharmaceuticals Inc (CE)
28/06/202313:01Edgar (US Regulatory)Current Report Filing (8-k)USOTC:ACURAcura Pharmaceuticals Inc (CE)
 Showing the most relevant articles for your search:USOTC:ACUR

Your Recent History

LSE
PRD
Predator Oil & Gas
LSE
RKH
Rockhopper Exploration
LSE
VTY
Vistry
LSE
GWMO
Great Western Mining
LSE
LLOY
Lloyds Banking
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved